Global Angiography Machine Market - 2025-2033

The global angiography machine market reached US$ 11.3 billion in 2024 and is expected to reach US$ 19.0 billion by 2033, growing at a CAGR of 6.0% during the forecast period 2025-2033.

An angiography machine is a specialized medical imaging system used to visualize the blood vessels, arteries, and veins of the body in real time. It utilizes X-ray, CT, or MRI technology, often combined with a contrast agent, to detect abnormalities such as blockages, aneurysms and vascular malformations. This angiography machine is a critical diagnostic and interventional tool in modern medicine, enabling real-time visualization of blood vessels to diagnose and treat various cardiovascular and neurological conditions. Its evolution includes AI-based imaging, hybrid systems, and mobile units, improving accessibility and accuracy in medical diagnostics.

The demand for angiography machines is growing rapidly due to several key factors, including the rising prevalence of cardiovascular diseases, advancements in technology, and the increasing adoption of minimally invasive procedures. For instance, acording to the Centers for Disease Control and Prevention, one person dies every 33 seconds from cardiovascular disease. In 2022, 702,880 people died from heart disease. That's the equivalent of 1 in every 5 deaths. As the cardiovascular diseases increase, demand for angiography machines has surged to diagnose coronary artery disease, peripheral artery disease and other vascular issues.

Market Dynamics: Drivers & Restraints

Rising technological advancements

The rising technological advancements is significantly driving the growth of the angiography machine market and is expected to drive the market over the forecast period. These innovations are improving diagnostic accuracy, minimizing patient risk and enhancing efficiency, making angiography machines more accessible and desirable. 3D angiography have revolutionized the way blood vessels are visualized. These technologies allow for better visualization of complex vascular structures, which is especially important for vascular surgeries and stent placements.

For instance, in September 2022, Siemens Healthineers launched ARTIS icono, an angiography system, in India. The angiography system has much improved 2D and 3D imaging capabilities, which improve picture quality and reduce radiation requirements. The cranial base and skull cap may be portrayed in 3D with virtually no artifacts to improved C-arm movement with Sine Spin. ARTIS icono Biplane will assist stroke centers in meeting the combined challenge of treating more patients, faster, and with more precision.

Artificial Intelligence (AI) algorithms are now being integrated into angiography systems to assist radiologists in automatically detecting abnormalities such as blockages, aneurysms, or stenosis in blood vessels. For instance, AI technologies are being incorporated into flat-panel detector (FPD) angiography systems to enhance image clarity and automatic detection of vascular anomalies, reducing human error and improving diagnostic accuracy.

Radiation exposure concerns

While angiography remains one of the most effective diagnostic and interventional tools for vascular diseases, concerns over radiation exposure are a significant factor limiting its growth. These concerns affect both patients and healthcare professionals, influencing the adoption and utilization of angiography machines.

Prolonged or repeated exposure to radiation from angiography machines can increase the risk of radiation-induced cancers, skin damage and other long-term health issues. This is particularly concerning for patients who require frequent angiography procedures for chronic conditions like coronary artery disease (CAD).

For instance, patients undergoing coronary angiography are at risk of accumulating high doses of radiation over time, which can lead to cancer risks. A study published in JACC (Journal of the American College of Cardiology) found that high cumulative radiation exposure from repeated cardiac angiography could raise the lifetime risk of cancer by up to 1.4% for a typical patient.

As awareness about radiation-induced health risks grows, patients may become hesitant to undergo angiography procedures, especially in the case of repeated scans or when alternative imaging methods like CT angiography or MRI angiography exist. This can reduce the demand for angiography machines in certain healthcare settings.

Segment Analysis

The global angiography machine market is segmented based on product type, technology, application, end-user and region.

Application:

The coronary angiography segment is expected to dominate the angiography machine market share

Cardiovascular diseases are the leading cause of death worldwide, with coronary artery disease (CAD) being one of the most common types of heart disease. As the global population ages and lifestyle-related risk factors such as obesity, diabetes, and smoking increase, there is a corresponding rise in the demand for coronary angiography to detect and treat these conditions.

For instance, the World Health Organization (WHO) reports that cardiovascular diseases account for 32% of global deaths, with coronary artery disease (CAD) being a major contributor. This has led to a high demand for coronary angiography as the gold standard for diagnosing blockages and narrowing of coronary arteries.

Coronary angiography is considered the gold standard for diagnosing coronary artery disease (CAD), providing a clear view of the coronary arteries, allowing cardiologists to evaluate blockages, stenosis, and the need for interventional procedures. For instance, in North America and Europe, coronary angiography is widely used in cardiac catheterization labs (Cath Labs) for diagnosis and treatment planning of patients with chest pain, shortness of breath, or risk factors for CAD, making it the dominant use case for angiography systems in these regions.

Geographical Analysis

North America is expected to hold a significant position in the angiography machine market share

North America particularly the United States is a hub for innovation in medical imaging technologies, and this extends to the angiography market. Continuous advancements in 3D imaging, digital subtraction angiography, real-time image guidance and AI integration have positioned North America at the forefront of adopting next-generation angiography systems.

For instance, Philips Healthcare and GE Healthcare, two major players in the angiography market, have developed cutting-edge systems such as the Philips Azurion and GE Innova platforms, which offer superior imaging clarity and reduced radiation exposure. These advanced systems are widely used across North America in cardiology, vascular surgery, and interventional radiology.

North America leads the adoption of hybrid angiography systems that combine traditional angiography with CT, MRI, or 3D imaging to provide a more comprehensive diagnostic approach. These systems offer real-time imaging and guidance, making them particularly useful for minimally invasive procedures like angioplasty, stent placement, and neurovascular interventions.

For instance, the growing trend of hybrid operating rooms, particularly in U.S. hospitals, is a key factor driving the demand for advanced angiography machines. Hybrid ORs integrate angiography systems with CT/MRI imaging, providing the flexibility to perform complex procedures like cardiac bypass surgeries and endovascular aneurysm repairs in a single setting.

Asia-Pacific is growing at the fastest pace in the angiography machine market

Cardiovascular diseases are on the rise in Asia-Pacific due to aging populations, urbanization, and the growing prevalence of risk factors such as smoking, poor diet, and lack of physical activity. As a result, there is an increasing demand for angiography as a diagnostic tool to detect and treat conditions like coronary artery disease (CAD), stroke, and peripheral artery disease (PAD).

For instance, in China, heart disease is the leading cause of death, with a significant rise in coronary artery disease cases, prompting the need for advanced diagnostic tools like angiography. According to the World Health Organization (WHO), more than 4 million deaths in China are attributed to CVDs, leading to growing demand for angiography procedures.

Medical tourism in APAC is also contributing to the growth of the angiography machine market, as countries like India, Thailand, and Singapore attract patients from developed countries seeking affordable, high-quality medical care. Many international patients travel to APAC for heart surgeries, angioplasties, and angiography due to the region's cost-effectiveness and high-quality healthcare services.

For instance, India is a major medical tourism destination, especially for cardiac procedures. Hospitals in cities like New Delhi, Chennai, and Bangalore are equipped with state-of-the-art angiography systems to cater to both local and international patients.

Competitive Landscape

The major global players in the angiography machine market include Siemens Healthineers AG, Canon Medical Systems ANZ Pty Limited., GE HealthCare, Shimadzu Corporation, Koninklijke Philips N.V., B. Braun SE and among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global angiography machine market report delivers a detailed analysis with 58 key tables, more than 65 visually impactful figures, and 149 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.